Zygomatic and Pterygoid Implants Market Report 2025

This Zygomatic and Pterygoid Implants market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The zygomatic and pterygoid implants market size has grown strongly in recent years. It will grow from $1.16 billion in 2024 to $1.23 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth during the historic period can be attributed to improved patient outcomes, a rising demand for complex dental solutions, an aging population, increased awareness of oral health, and a growing acceptance of innovative dental treatments.

The zygomatic and pterygoid implants market size is expected to see strong growth in the next few years. It will grow to $1.57 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The expected growth in the forecast period is driven by the expansion of dental healthcare facilities, the rise in dental tourism, increasing disposable incomes, enhanced diagnostic capabilities, and better patient education. Key trends during this period include advancements in implant technology, the development of minimally invasive techniques, technological innovations, integration with 3D printing technology, and further progress in cutting-edge dental technologies.

The increasing prevalence of oral diseases is expected to drive the growth of the zygomatic and pterygoid implants market. Oral diseases encompass a variety of conditions that affect the mouth, teeth, gums, and surrounding tissues, such as cavities, gum disease, oral infections, and oral cancer. These conditions are often caused by poor hygiene, dietary habits, or underlying health problems. The rise in oral diseases can be attributed to factors such as inadequate oral hygiene, diets high in sugar, limited access to dental care, and growing rates of tobacco and alcohol use. Zygomatic and pterygoid implants offer a solution by providing stable support for dental prostheses in patients with severe bone loss, improving overall oral health, and restoring function when traditional implants are not viable. For example, in November 2024, the World Health Organization (WHO) reported that, in 2022, approximately 3.5 billion people worldwide suffered from oral diseases, with 75% of these individuals living in middle-income countries. Among these, 2 billion people had caries in permanent teeth, and 514 million children were affected by caries in primary teeth. As such, the growing prevalence of oral diseases is driving demand for zygomatic and pterygoid implants.

Companies in the zygomatic and pterygoid implants market are focusing on innovative solutions, such as metal-free implants, to meet the needs of patients with metal allergies, improve biocompatibility, and enhance long-term treatment outcomes. Metal-free implants are made entirely from non-metallic materials, such as ceramics or polymers, which are biocompatible and designed to reduce metal-related allergic reactions, corrosion, or interference with medical imaging technologies such as MRI. For example, in December 2024, Pure Dental Health, a premier dental practice based in the US, launched its advanced All-on-X dental implant system. This system features zygomatic and pterygoid implants to address severe bone loss and complex dental conditions, providing patients with secure, natural-looking smiles and restoring both functionality and confidence, regardless of the complexity of their dental needs.

In May 2023, Henry Schein Inc., a US-based healthcare company, acquired S.I.N. Implant System for an undisclosed amount. With this acquisition, Henry Schein aims to enhance its dental implant portfolio and expand its global presence in the advanced dental solutions market. S.I.N. Implant System is a Brazil-based company specializing in dental implants, including zygomatic and pterygoid implants.

Major players in the zygomatic and pterygoid implants market are Zimmer Biomet Holding Inc., Straumann Holding A.G., Nobel Biocare, Biohorizons Implant Systems Inc., MIS Implants Technologies Ltd., Biotec Dental Implants, Sistema de Implante Nacional S.A., IQ Implants Ltd., Adin Dental Implant Systems Ltd., Southern Implants (Pty) Ltd., CORTEX Dental Implants Industries Ltd., Camlog Vertriebs GmbH, Noris Medical Ltd., Jeil Medical Corporation, Paltop Advance Dental Solutions Ltd., IDC Implant & Dental Company, Bioline Dental Private Limited, Biologitech Srl., Implantswis AG, and B&B Dental Implant Company.

North America was the largest region in the zygomatic and pterygoid implants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in zygomatic and pterygoid implants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the zygomatic and pterygoid implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Zygomatic and pterygoid implants are specialized dental implants that are anchored in the zygomatic bone (cheekbone) and pterygoid bone (located near the back of the upper jaw), respectively. These implants are designed for patients who have experienced severe bone loss in the upper jaw, offering stable support for dental prostheses when traditional implants are not an option.

The primary types of zygomatic and pterygoid implants include zygomatic implants, pterygoid implants, and combined implants. Zygomatic implants are specialized implants secured in the cheekbone to provide stable, long-lasting support for prosthetics in cases of significant upper jaw bone loss. They come in various lengths, such as up to 30 mm, 30-50 mm, and over 50 mm, and are used in applications such as maxillary sinuses and severe atrophy of the maxillary bone. These implants are commonly used by dental clinics, hospital dental departments, and research institutions.

The zygomatic and pterygoid implants market research report is one of a series of new reports that provides zygomatic and pterygoid implants market statistics, including the zygomatic and pterygoid implants industry global market size, regional shares, competitors with the zygomatic and pterygoid implants market share, detailed zygomatic and pterygoid implants market segments, market trends, and opportunities, and any further data you may need to thrive in the zygomatic and pterygoid implants industry. This zygomatic and pterygoid implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The zygomatic and pterygoid implants market consists of sales of implant abutments, guided surgery kits, and prosthetics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.